Gemfibrozil treatment: a comparison with clofibrate
- PMID: 190609
- PMCID: PMC1864044
- DOI: 10.1177/00359157760690S222
Gemfibrozil treatment: a comparison with clofibrate
Abstract
Gemfibrozil was found to be an effective hypotriglyceridaemic agent in types IV, IIb and V hyperlipoproteinaemia. When given at a dose level of 800 mg/day its activity was nearly of the same order of magnitude as 1.5 g/day of clofibrate.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources